2025年病理学人工智慧全球市场报告

预计未来几年病理学人工智慧市场规模将快速成长。到 2029 年，这一数字将成长至 23.1 亿美元，复合年增长率为 13.5%。预测期内的成长可归因于临床试验中人工智慧的成长、医疗保健基础设施的扩展、多学科合作、明确的道德准则的製定以及基于人工智慧的预测分析的发展。预测期内的主要趋势包括基于人工智慧的诊断工具的开发、与电子健康记录病历的整合、电脑辅助诊断 (CAD)、基于人工智慧的生物标记发现以及与基因组资料的整合。

个人化医疗日益增长的需求预计将在未来几年推动病理学人工智慧市场的扩张。个人化医疗是根据每位患者的特征、需求和偏好製化治疗和保健。这种日益增长的需求源于根据个人的基因图谱、生活方式因素和特定疾病特征量身定制治疗的能力，从而提高疗效并最大限度地减少副作用。病理学中的人工智慧 (AI) 透过更精确、更有效地分析医疗图像和遗传资料，实现更准确的诊断、识别疾病亚型以及根据患者独特的生物学特征制定个性化治疗计划，为个性化医疗做出了贡献。例如，美国专家会员组织个人化医疗联盟2023年2月发布的报告显示，2022年核准了12种新的个人化药物，约占所有新治疗方法的34%，较前几年有显着成长。因此，个人化医疗需求的不断增长是推动病理学人工智慧市场成长的关键因素。

病理学人工智慧市场的主要企业正专注于创造先进的解决方案，例如尖端癌症检测工具，旨在提高诊断准确性、简化工作流程并改善患者预后。这些先进的癌症检测工具由人工智慧驱动，使用机器学习演算法和深度学习模型来分析医学影像和病理切片，以提高肿瘤检测和分类的准确性。例如，美国数位病理诊断公司Paige.ai于2022年3月宣布推出Paige淋巴结模组，帮助病理学家检测已扩散到淋巴结的乳癌。该工具能够检测所有大小的乳癌转移，包括小的微转移，灵敏度超过 98%，并采用专有的 TissueMap 突出显示淋巴结载玻片上的可疑区域，提高病理学家审查的效率和准确性，同时显着减少分析所需的时间。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场 - 宏观经济情景，包括利率、感染疾病、地缘政治、新冠疫情、经济復苏对市场的影响

第五章 全球成长分析与策略分析框架

• 全球病理学中的人工智慧PESTEL分析（政治、社会、技术、环境、法律因素、驱动因素和限制因素）
• 最终用途产业分析
• 全球病理学人工智慧市场：成长率分析
• 全球病理学人工智慧市场表现：规模与成长，2019-2024
• 全球病理学人工智慧市场预测：规模与成长，2024-2029 年，2034 年
• 全球病理学人工智慧总目标市场（TAM）

第六章市场区隔

• 全球病理学人工智慧市场：按组成部分、性能和预测，2019-2024 年、2024-2029 年、2034 年
• 软体
• 扫描器
• 全球病理学人工智慧市场（按神经网路划分）现状及预测（2019-2024 年、2024-2029 年及 2034 年）
• 生成对抗网络
• 卷积类神经网路
• 传统神经网络
• 循环神经网络
• 其他神经网络
• 全球病理学人工智慧市场的应用、表现及预测（2019-2024 年、2024-2029 年及 2034 年）
• 药物研发
• 疾病的诊断和预后
• 临床工作流程
• 培训和教育
• 全球病理学人工智慧市场（按最终用户、绩效及预测），2019-2024 年、2024-2029 年及 2034 年
• 製药和生物技术公司
• 医院和参考实验室
• 学术研究所
• 全球病理学人工智慧市场细分（按软体类型、实际及预测），2019-2024 年、2024-2029 年、2034 年
• 影像分析软体
• 诊断工作流程软体
• 预测分析软体
• 全球病理学人工智慧市场，按扫描器类型细分，性能和预测，2019-2024 年、2024-2029 年、2034 年
• 全切片成像扫描仪
• 数位病理扫描仪
• 频谱成像扫描仪

第七章 区域和国家分析

• 全球病理学人工智慧市场：按地区、绩效及预测，2019-2024 年、2024-2029 年、2034 年
• 全球病理学人工智慧市场：按国家、绩效及预测，2019-2024 年、2024-2029 年、2034 年

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章 澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章 德国市场

第十八章 法国市场

第十九章：义大利市场

第20章：西班牙市场

第21章 东欧市场

第22章 俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第30章竞争格局与公司概况

• 病理学人工智慧市场：竞争格局
• 病理学市场中的人工智慧：公司简介
  • F. Hoffmann-La Roche Ltd Overview, Products and Services, Strategy and Financial Analysis
  • Koninklijke Philips NV Overview, Products and Services, Strategy and Financial Analysis
  • Hamamatsu Photonics KK Overview, Products and Services, Strategy and Financial Analysis
  • Leica Biosystems Overview, Products and Services, Strategy and Financial Analysis
  • Tempus Labs Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章 其他大型创新企业

• Spectra AB
• Lunit Inc.
• Paige AI Inc.
• Inspirata Inc.
• Indica Labs Inc.
• Flagship Biosciences Inc
• Proscia Inc.
• Aiforia Technologies Oy
• Lumea Inc.
• Optrascan Inc.
• PathAI Inc.
• Visiopharm A/S
• Ibex Medical Analytics Ltd.
• BioSymetrics Inc.
• Deep Bio Inc.

第 32 章全球市场竞争基准化分析与仪表板

第33章 重大併购

第34章近期市场趋势

第 35 章 高市场潜力国家、细分市场与策略

• 2029年病理学市场中的人工智慧：提供新机会的国家
• 2029年病理学人工智慧市场：细分领域带来新机会
• 2029年病理学人工智慧市场：成长策略
  • 基于市场趋势的策略
  • 竞争对手的策略

第36章 附录

Artificial intelligence (AI) in pathology refers to the application of machine learning algorithms and deep learning models to assist in the analysis of medical images, pattern recognition, and disease diagnosis. AI aids pathologists by automating tasks such as slide analysis, tumor detection, and grading, thereby enhancing diagnostic accuracy and efficiency. It also enables quicker processing of large datasets, which is essential for personalized medicine.

The primary components of artificial intelligence in pathology include software and scanners. Software consists of a collection of programs and algorithms specifically designed to perform tasks related to pathology, such as analyzing medical images, managing data, and supporting diagnostic and research activities. This technology employs various types of neural networks, including generative adversarial networks, convolutional neural networks, conventional neural networks, recurrent neural networks, and others. AI in pathology is utilized in drug discovery, disease diagnosis and prognosis, clinical workflows, as well as training and education. The users of these technologies encompass pharmaceutical and biotechnology companies, hospitals and reference laboratories, and academic and research institutions.

The artificial intelligence in pathology market research report is one of a series of new reports from The Business Research Company that provides artificial intelligence in pathology market statistics, including artificial intelligence in pathology industry global market size, regional shares, competitors with a artificial intelligence in pathology market share, detailed artificial intelligence in pathology market segments, market trends and opportunities, and any further data you may need to thrive in the artificial intelligence in pathology industry. This artificial intelligence in pathology market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The artificial intelligence in pathology market size has grown rapidly in recent years. It will grow from $1.22 billion in 2024 to $1.39 billion in 2025 at a compound annual growth rate (CAGR) of 13.8%. The growth in the historic period can be attributed to increasing prevalence of disease, increasing funding initiatives, increasing use of telemedicine, increasing government initiatives, and increasing the demand for pathology services.

The artificial intelligence in pathology market size is expected to see rapid growth in the next few years. It will grow to $2.31 billion in 2029 at a compound annual growth rate (CAGR) of 13.5%. The growth in the forecast period can be attributed to the growth of AI in clinical trials, expanding healthcare infrastructure, interdisciplinary collaborations, the development of clear ethical guidelines, and the development of AI-based predictive analytics. Major trends in the forecast period include development of AI-powered diagnostic tools, integration with electronic health records, computer-aided diagnosis (CAD), AI-driven biomarker discovery, and integration with genomic data.

The growing demand for personalized medicine is projected to drive the expansion of the artificial intelligence in pathology market in the future. Personalized medicine involves tailoring medical treatment and healthcare to the unique characteristics, needs, and preferences of each patient. This rising need is attributed to the ability to customize treatments based on individual genetic profiles, lifestyle factors, and specific disease characteristics, thereby enhancing efficacy and minimizing adverse effects. Artificial intelligence (AI) in pathology contributes to personalized medicine by facilitating more accurate and efficient analyses of medical images and genetic data, allowing for more precise diagnoses, improved identification of disease subtypes, and tailored treatment plans that align with a patient's unique biological profile. For instance, a report from the Personalized Medicine Coalition, a US-based professional membership organization, revealed in February 2023 that 12 new personalized medicines were approved in 2022, accounting for about 34% of all new therapies, marking a significant increase compared to previous years. Therefore, the growing demand for personalized medicine is a key factor driving the growth of the artificial intelligence in pathology market.

Leading companies in the artificial intelligence in pathology market are focusing on creating advanced solutions, such as cutting-edge cancer detection tools, to improve diagnostic accuracy, streamline workflows, and enhance patient outcomes. These advanced cancer detection tools utilize AI, leveraging machine learning algorithms and deep learning models to analyze medical images and pathology slides, thereby increasing the accuracy of tumor detection and classification. For example, in March 2022, Paige.ai, a US-based digital pathology company, launched the Paige Lymph Node Module to assist pathologists in detecting breast cancer metastases in lymph nodes. This tool features over 98% sensitivity in detecting breast cancer metastases of any size, including small micrometastases, and employs a proprietary TissueMap to highlight suspicious areas on lymph node slides, enhancing the efficiency and accuracy of pathologists' reviews while significantly reducing the time needed for analysis.

In March 2023, Clarapath, a US-based medical robotics firm, acquired Crosscope for an undisclosed amount. This acquisition aims to enhance Crosscope's digital pathology platform by integrating advanced workflow tools and AI capabilities with Clarapath's automated tissue sectioning system, ultimately improving efficiency and accuracy in pathology laboratories. Crosscope is a US-based company that develops a digital pathology imaging platform that incorporates artificial intelligence to enhance analysis and diagnostics in the field of pathology.

Major companies operating in the artificial intelligence in pathology market are F. Hoffmann-La Roche Ltd, Koninklijke Philips N.V., Hamamatsu Photonics K.K., Leica Biosystems, Tempus Labs Inc., Spectra AB, Lunit Inc., Paige AI Inc., Inspirata Inc., Indica Labs Inc., Flagship Biosciences Inc, Proscia Inc., Aiforia Technologies Oy, Lumea Inc., Optrascan Inc., PathAI Inc., Visiopharm A/S, Ibex Medical Analytics Ltd., BioSymetrics Inc., Deep Bio Inc., Konfoong Biotech International Co Ltd., Mindpeak GmbH, Qritive Inc., Vuno Inc.

Asia-Pacific was the largest region in the artificial intelligence in pathology market in 2023. North America is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial intelligence in pathology market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the artificial intelligence in pathology market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The artificial intelligence in pathology market consists of revenues earned by entities by providing services such as automated diagnostics, image analysis and interpretation, workflow optimization, and remote and telepathology. The market value includes the value of related goods sold by the service provider or included within the service offering. The artificial intelligence in pathology market also includes sales of high-resolution scanners, graphics processing units (GPUs), workstations, and storage systems. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Artificial Intelligence In Pathology Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on artificial intelligence in pathology market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for artificial intelligence in pathology ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The artificial intelligence in pathology market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Component: Software; Scanners
• 2) By Neural Network: Generative Adversarial Networks; Convolutional Neural Networks; Conventional Neural Network; Recurrent Neural Networks; Other Neural Networks
• 3) By Application: Drug Discovery; Disease Diagnosis And Prognosis; Clinical Workflow; Training And Education
• 4) By End User: Pharmaceutical And Biotechnology Companies; Hospitals And Reference Laboratories; Academic And Research Institutes
• Subsegments:
• 1) By Software: Image Analysis Software; Diagnostic Workflow Software; Predictive Analytics Software
• 2) By Scanners: Whole Slide Imaging Scanners; Digital Pathology Scanners; Multi-Spectral Imaging Scanners
• Companies Mentioned: F. Hoffmann-La Roche Ltd; Koninklijke Philips N.V.; Hamamatsu Photonics K.K.; Leica Biosystems; Tempus Labs Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Artificial Intelligence In Pathology Market Characteristics

3. Artificial Intelligence In Pathology Market Trends And Strategies

4. Artificial Intelligence In Pathology Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Artificial Intelligence In Pathology Growth Analysis And Strategic Analysis Framework

• 5.1. Global Artificial Intelligence In Pathology PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Artificial Intelligence In Pathology Market Growth Rate Analysis
• 5.4. Global Artificial Intelligence In Pathology Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Artificial Intelligence In Pathology Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Artificial Intelligence In Pathology Total Addressable Market (TAM)

6. Artificial Intelligence In Pathology Market Segmentation

• 6.1. Global Artificial Intelligence In Pathology Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Software
• Scanners
• 6.2. Global Artificial Intelligence In Pathology Market, Segmentation By Neural Network, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Generative Adversarial Networks
• Convolutional Neural Networks
• Conventional Neural Network
• Recurrent Neural Networks
• Other Neural Networks
• 6.3. Global Artificial Intelligence In Pathology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Drug Discovery
• Disease Diagnosis And Prognosis
• Clinical Workflow
• Training And Education
• 6.4. Global Artificial Intelligence In Pathology Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Pharmaceutical And Biotechnology Companies
• Hospitals And Reference Laboratories
• Academic And Research Institutes
• 6.5. Global Artificial Intelligence In Pathology Market, Sub-Segmentation Of Software, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Image Analysis Software
• Diagnostic Workflow Software
• Predictive Analytics Software
• 6.6. Global Artificial Intelligence In Pathology Market, Sub-Segmentation Of Scanners, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Whole Slide Imaging Scanners
• Digital Pathology Scanners
• Multi-Spectral Imaging Scanners

7. Artificial Intelligence In Pathology Market Regional And Country Analysis

• 7.1. Global Artificial Intelligence In Pathology Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Artificial Intelligence In Pathology Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Artificial Intelligence In Pathology Market

• 8.1. Asia-Pacific Artificial Intelligence In Pathology Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Artificial Intelligence In Pathology Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Artificial Intelligence In Pathology Market, Segmentation By Neural Network, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Artificial Intelligence In Pathology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Artificial Intelligence In Pathology Market

• 9.1. China Artificial Intelligence In Pathology Market Overview
• 9.2. China Artificial Intelligence In Pathology Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Artificial Intelligence In Pathology Market, Segmentation By Neural Network, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Artificial Intelligence In Pathology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Artificial Intelligence In Pathology Market

• 10.1. India Artificial Intelligence In Pathology Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Artificial Intelligence In Pathology Market, Segmentation By Neural Network, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Artificial Intelligence In Pathology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Artificial Intelligence In Pathology Market

• 11.1. Japan Artificial Intelligence In Pathology Market Overview
• 11.2. Japan Artificial Intelligence In Pathology Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Artificial Intelligence In Pathology Market, Segmentation By Neural Network, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Artificial Intelligence In Pathology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Artificial Intelligence In Pathology Market

• 12.1. Australia Artificial Intelligence In Pathology Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Artificial Intelligence In Pathology Market, Segmentation By Neural Network, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Artificial Intelligence In Pathology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Artificial Intelligence In Pathology Market

• 13.1. Indonesia Artificial Intelligence In Pathology Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Artificial Intelligence In Pathology Market, Segmentation By Neural Network, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Artificial Intelligence In Pathology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Artificial Intelligence In Pathology Market

• 14.1. South Korea Artificial Intelligence In Pathology Market Overview
• 14.2. South Korea Artificial Intelligence In Pathology Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Artificial Intelligence In Pathology Market, Segmentation By Neural Network, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Artificial Intelligence In Pathology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Artificial Intelligence In Pathology Market

• 15.1. Western Europe Artificial Intelligence In Pathology Market Overview
• 15.2. Western Europe Artificial Intelligence In Pathology Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Artificial Intelligence In Pathology Market, Segmentation By Neural Network, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Artificial Intelligence In Pathology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Artificial Intelligence In Pathology Market

• 16.1. UK Artificial Intelligence In Pathology Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Artificial Intelligence In Pathology Market, Segmentation By Neural Network, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Artificial Intelligence In Pathology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Artificial Intelligence In Pathology Market

• 17.1. Germany Artificial Intelligence In Pathology Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Artificial Intelligence In Pathology Market, Segmentation By Neural Network, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Artificial Intelligence In Pathology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Artificial Intelligence In Pathology Market

• 18.1. France Artificial Intelligence In Pathology Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Artificial Intelligence In Pathology Market, Segmentation By Neural Network, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Artificial Intelligence In Pathology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Artificial Intelligence In Pathology Market

• 19.1. Italy Artificial Intelligence In Pathology Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Artificial Intelligence In Pathology Market, Segmentation By Neural Network, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Artificial Intelligence In Pathology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Artificial Intelligence In Pathology Market

• 20.1. Spain Artificial Intelligence In Pathology Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Artificial Intelligence In Pathology Market, Segmentation By Neural Network, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Artificial Intelligence In Pathology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Artificial Intelligence In Pathology Market

• 21.1. Eastern Europe Artificial Intelligence In Pathology Market Overview
• 21.2. Eastern Europe Artificial Intelligence In Pathology Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Artificial Intelligence In Pathology Market, Segmentation By Neural Network, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Artificial Intelligence In Pathology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Artificial Intelligence In Pathology Market

• 22.1. Russia Artificial Intelligence In Pathology Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Artificial Intelligence In Pathology Market, Segmentation By Neural Network, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Artificial Intelligence In Pathology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Artificial Intelligence In Pathology Market

• 23.1. North America Artificial Intelligence In Pathology Market Overview
• 23.2. North America Artificial Intelligence In Pathology Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Artificial Intelligence In Pathology Market, Segmentation By Neural Network, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Artificial Intelligence In Pathology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Artificial Intelligence In Pathology Market

• 24.1. USA Artificial Intelligence In Pathology Market Overview
• 24.2. USA Artificial Intelligence In Pathology Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Artificial Intelligence In Pathology Market, Segmentation By Neural Network, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Artificial Intelligence In Pathology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Artificial Intelligence In Pathology Market

• 25.1. Canada Artificial Intelligence In Pathology Market Overview
• 25.2. Canada Artificial Intelligence In Pathology Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Artificial Intelligence In Pathology Market, Segmentation By Neural Network, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Artificial Intelligence In Pathology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Artificial Intelligence In Pathology Market

• 26.1. South America Artificial Intelligence In Pathology Market Overview
• 26.2. South America Artificial Intelligence In Pathology Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Artificial Intelligence In Pathology Market, Segmentation By Neural Network, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Artificial Intelligence In Pathology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Artificial Intelligence In Pathology Market

• 27.1. Brazil Artificial Intelligence In Pathology Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Artificial Intelligence In Pathology Market, Segmentation By Neural Network, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Artificial Intelligence In Pathology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Artificial Intelligence In Pathology Market

• 28.1. Middle East Artificial Intelligence In Pathology Market Overview
• 28.2. Middle East Artificial Intelligence In Pathology Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Artificial Intelligence In Pathology Market, Segmentation By Neural Network, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Artificial Intelligence In Pathology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Artificial Intelligence In Pathology Market

• 29.1. Africa Artificial Intelligence In Pathology Market Overview
• 29.2. Africa Artificial Intelligence In Pathology Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Artificial Intelligence In Pathology Market, Segmentation By Neural Network, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Artificial Intelligence In Pathology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Artificial Intelligence In Pathology Market Competitive Landscape And Company Profiles

• 30.1. Artificial Intelligence In Pathology Market Competitive Landscape
• 30.2. Artificial Intelligence In Pathology Market Company Profiles
  • 30.2.1. F. Hoffmann-La Roche Ltd Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Koninklijke Philips N.V. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Hamamatsu Photonics K.K. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Leica Biosystems Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Tempus Labs Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Artificial Intelligence In Pathology Market Other Major And Innovative Companies

• 31.1. Spectra AB
• 31.2. Lunit Inc.
• 31.3. Paige AI Inc.
• 31.4. Inspirata Inc.
• 31.5. Indica Labs Inc.
• 31.6. Flagship Biosciences Inc
• 31.7. Proscia Inc.
• 31.8. Aiforia Technologies Oy
• 31.9. Lumea Inc.
• 31.10. Optrascan Inc.
• 31.11. PathAI Inc.
• 31.12. Visiopharm A/S
• 31.13. Ibex Medical Analytics Ltd.
• 31.14. BioSymetrics Inc.
• 31.15. Deep Bio Inc.

32. Global Artificial Intelligence In Pathology Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Artificial Intelligence In Pathology Market

34. Recent Developments In The Artificial Intelligence In Pathology Market

35. Artificial Intelligence In Pathology Market High Potential Countries, Segments and Strategies

• 35.1 Artificial Intelligence In Pathology Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Artificial Intelligence In Pathology Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Artificial Intelligence In Pathology Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer